News | Enterprise Imaging | December 01, 2020

Momentum Continues for Visage at RSNA 2020

Visage 7 Live Connect enables simple radiologist collaboration with referrers

Visage 7 Live Connect enables simple radiologist collaboration with referrers

December 1, 2020 — Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage 7 Enterprise Imaging Platform, featuring the introduction of Visage 7 Live Connect (as a works-in-progress), at the virtual Radiological Society of North America (RSNA) 2020 annual meeting, from Sunday, November 29 – Saturday, December 5, 2020.

Visage has proven especially resilient during the global pandemic. The company's leading-edge technology enables radiologists to read remotely with lightning-fast speed and diagnostic precision regardless of the size or type of examination(s). Go-lives for both on-premise and public-cloud based implementations have continued throughout, underpinned by the company's ability to provide remote training and support regardless of the scale or complexity of the implementation. This has further strengthened Visage's reputation for seamless replacement of legacy PACS.

Healthcare institutions are seeking modern, flexible solutions and have a heightened awareness of security due to the increasing threat of malware and ransomware attacks. These factors, in combination with the relentless growth of imaging datasets, continue to present architectural and performance hurdles for imaging organizations reliant on legacy PACS with 'compress and send' limitations and inferior server-side technology.

"Today's Enterprise Imaging challenges institutions with constantly evolving requirements," explained Malte Westerhoff, Ph.D., Visage Imaging Co-Founder and Chief Technology Officer. Westerhoff continued, "At Visage, we continue to implement leading design principles with Visage 7 that enhance capabilities, improve performance and tighten security. This allows our customers to remain a step ahead of their increasing clinical needs and the threats that they must navigate. Visage continues to innovate with significant velocity, rapidly getting new features into clinical use. With Visage 7 Live Connect, we're enabling radiologists to easily share images with referring physicians during interpretation, without disruption to diagnostic reading workflow. The simplicity of collaboration will encourage radiologists to utilize imaging communications in ways that were previously not thought possible, to include the potential for collaboration with patients and their imaging."

At RSNA 2020, the following highlights will be demonstrated and discussed:

  • Visage 7 Live Connect. Visage 7 Live Connect empowers collaboration, making real-time communications easy. Radiologists will be able to immediately and securely collaborate, sharing images with referrers directly from Visage 7 during interpretation workflow. The radiologist will simply pass a secure link and session code to all intended recipients for real-time viewing from any HTML browser using any of their preferred devices (e.g., desktop, mobile, tablet). Even though radiologists typically use multiple high-resolution diagnostic displays, and referring physicians may use a single display or a mobile device, Visage 7 Live Connect is not restricted due to any potential display or device type mismatch. Instead, collaborative image viewing is optimally focused on the radiologist's active viewer, does not require recipient users have any installed software or account(s) on Visage 7, and all recipients are able to view shared cursor movements from one or multiple screen share participants.
  • Transcatheter Aortic Valve Replacement (TAVR) Planning. Demonstrated as a works-in-progress, Visage 7 supports a new Triangle tool for TAVR planning. This tool automatically repositions all of the MPR viewers, so the axial view is in plane with the valve where the leaflets join. This rapidly allows the radiologist to drop 3 points simplifying the capture of TAVR planning measurements.
  • Visage In The Cloud - SAML. Visage 7 now natively supports the Security Assertion Markup Language (SAML) open standard for secure single-sign on (SSO) solutions with an identity provider for public cloud implementations of Visage 7.
  • Visage AI Accelerator – Iterative Learning Cycle. The Visage AI Accelerator is an end-to-end AI solution that bridges both research and diagnostic imaging with the same, unified platform. Visage will demonstrate and discuss how Visage 7 plays a central, integrated role in the AI pipeline, accelerating iterative learning and ground truth development with innovative native tools, fostering an optimized train/validate/enhance cycle.

Visage is also a proud participant in the Imaging AI in Practice (IAIP) demonstration, a multi-vendor interoperability demonstration highlighting new technologies and communications standards needed to integrate AI into the diagnostic radiology workflow. Click here to view the IAIP demonstration's "Evolve with AI" video, found in the RSNA 2020 AI Showcase [Note: RSNA 2020 registration is required for viewing].

Visage's virtual RSNA 2020 exhibit is available to registered attendees via this direct link. To schedule a priority virtual demonstration of Visage 7 at RSNA 2020, please click here for additional details. Experience Visage's all-new website here.

Related Content

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Futuristic campus design of Siemens Healthineers in Bengaluru, India.

Futuristic campus design of Siemens Healthineers in Bengaluru, India.

News | Radiology Business | April 08, 2021
April 8, 2021 — Siemens Healthineers announced t
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.